Professional Documents
Culture Documents
Kenya 4Ds Data Profile FINAL
Kenya 4Ds Data Profile FINAL
October 2021
Kenya is undergoing four key transitions in its health sector—demographic transition, changes in disease burden, a transi-
tion away from development assistance for health, and a shift towards domestic financing for health. Despite health gains
in previous decades, Kenya is facing a high burden of communicable diseases and a rapidly increasing burden of non-com-
municable diseases (NCDs). It is also experiencing high population growth and financial challenges resulting from donor
transitions. In this profile, we summarize the key transitions that will have an impact on achieving universal health coverage
(UHC) in Kenya.
This is one in a series focusing on middle-income countries that are transitioning out of official development
assistance for health. The profiles are part of a broader study called Driving health progress during disease,
demographic, domestic finance, and donor transitions led by the Center for Policy Impact in Global Health.
Kenya's health sector transitions: impact data summary n 2
Demographic transition
Key takeaways
• Between now and 2050, Kenya’s population structure will rapidly grow, urbanize, and informal sector (thereby leaving them unqualified for employer-provided insurance),
age, creating profound challenges for the healthcare system. and are at higher risk of NCDs and injuries.
• To achieve UHC, annual health spending per person needs to grow faster than the • Healthcare in Kenya will need to evolve to tackle the increasing burden of risk factors
rapidly growing population. associated with a rapidly urbanizing population and the changing geographic distribu-
• Currently, Kenya has a “young” population. Kenya will need to address the health con- tion of health service needs.
cerns of its youth, who face high unemployment rates, work disproportionately in the
1983
1984
1985
1988
1982
1986
1987
1989
1991
1992
1993
1995
1996
1997
1999
2003
2004
2005
2010
2000
2001
2014
2016
2017
1998
2006
2008
2009
2011
2012
2019
1990
1994
2002
2007
2013
2015
2018
Main causes of mortality Adult morbidity and mortality (15-59 years) Neonatal mortality rate & maternal mortality ratios
Deaths, rate per 100,000 population 60,000 900 30 800
Deaths (rate per 100,000 population)
DALYs (rate per 1000,000 population)
4%, 13,413
6%, 18,555 800
7%, 20,463 50,000 700
25
19%, 60,782 700
600
30,000
400 15 400
Development Indicator7
10,000 200
54%, 158,901
100 5
100
0 0
0 0
2001
2005
2007
2008
2014
2010
2011
2000
2003
2002
2004
2006
2009
2012
2013
2015
2016
2017
37%, 6,514,141
1 HIV/AIDS & STIs HIV/AIDS & STIs Enteric infections
Communicable, maternal, neo-
252,756 200,906 158,901 -2%
Source: Institute for Health Metrics and
2 RIs and TB RTIs and TB Cardiovascular diseases natal, and nutritional diseases
79%, 16,615,777
67%, 13,018,387 3 Enteric infections Cardiovascular diseases RTIs and TB NCDs 60,782 90,473 114,524 3%
56%, 9,981,772 4 Maternal & Neonatal Enteric infections Neoplasms
Source: Global Health
Abbreviations: RIs, respiratory infections; TB: tuberculosis; NTDs, neglected tropical diseases; STIs, sexually transmitted infections; NCDs, non-communicable diseases; DALYs, disability-adjusted life years; AROC, annual rate of change.
Kenya's health sector transitions: impact data summary n 3
Domestic finance transition
Key takeaways
• Kenya’s domestic financing for healthcare is showing positive trends: domestic cuts for key initiatives like UHC.13 Achieving UHC by 2022 in the current economic
financing is increasing as a share of total health spending while external financing and climate remains a herculean task.
out-of-pocket payments (OOPs) are declining. • Kenya’s domestic revenue mobilization and budget execution capacity will need to
• However, the COVID-19 pandemic has strained Kenya’s economy, leading to budget improve to sustainably finance UHC.
200
Health expenditure (2019, US$ billions) Health expenditure per capita (by sources) Source of health financing
Int$ (PPP)
3.1 0.7
Expenditure Database5
0.6 80
0.5
Kenya 28
29 29 26 24 23 20 18 16
income countries 29 29 16 16
expenditure)
EXT (% of current health 12.4 15.5 1% 3.50% 3.20% -0.05%
expenditure)
43 43 42
OOPS (% of current health 47.1 23.6 -4% 59.20% 55.70% -0.03% 34
37
40
30 31 32
expenditure) 29 29 29 26 28
25 26 27 28 29
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
External health expenditure as a percentage of domestic GGHE-D Aid received by health area 2009-2018
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Health area Total flow Total flow
115%
110% 106% 105% 99%
85% (US$ millions) (percentage)
Source: WHO’s Global Health
73% 75%
67%
62%
54%
STD control including HIV/AIDS 5334.0 63.2%
Expenditure Database5
54%
43% 44% 47% 44%
38% 37% 37%
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 Infectious disease control 144.1 1.7%
Basic health care 634.3 7.5%
Reproductive health care 358.9 4.2%
Aid by top 5 donors each year from 2010-2019 (US$ millions)
$1,000.00
$900.00
Health policy & administrative management 400.9 4.7%
GAVI
Tuberculosis control 219.1 2.6%
$800.00 World Bank Group
Source: Organization for Economic Co-oporation and Development (OECD)16
reproductive health
Source: Organization for Economic
$400.00
Medical services 54.8 0.6%
$300.00
Health education 17.6 0.2%
$200.00
Health personnel development 10.1 0.1%
$100.00
Medical research 32.7 0.4%
$- Basic health infrastructure 36.9 0.4%
2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Medical education/training 4.1 0.0%
Abbreviations: GGHE-D, domestic general government health expenditure; STD, sexually transmitted disease.
Kenya's health sector transitions: impact data summary n 4
Donor health aid transition (continued) United States aid to health (US$ millions)
700
Top 5 donors (91%, US$7.7 billion, of all ODA for health, 2010-2019) 10 3
Other
9
23 Basic nutrition
Donor Total Percentage
46
Gavi, the Vaccine Alliance $382.74 5%
300
Other $788.86 9% 576
(OECD)16
4 Infectious disease control
Family planning 0
1 Malaria control
17 7 140
4 10 24 STD control including HIV/AIDS
10 1
Development16
20
16 16 120
61
11 13 3 12
8 1 10 1 8
7 12 5 16 18
4 100
0 12
70
5
3 Other
0
2 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
60 2 Infectious disease control 80
50
Co-oporation and Development16
30 27 13 0 12
2 6
15 5 1 40
7 6
3
Note: Other areas include basic health care, health policy and administrative management,
and family planning 0
2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
This is one in a series focusing on middle-income countries that are transitioning out of official development assistance for
health. The profiles are part of a broader study called Driving health progress during disease, demographic, domestic finance,
and donor transitions led by the Center for Policy Impact in Global Health.